Safety and Efficacy of Edoxaban and Rivaroxaban to Cerebral Venous Thrombosis in Chinese Patients
RecruitingOBSERVATIONAL
Enrollment
1,486
Participants
Timeline
Start Date
April 10, 2025
Primary Completion Date
December 31, 2027
Study Completion Date
December 31, 2027
Conditions
Cerebral Venous ThrombosisAnticoagulants and Thrombotic DisordersAnticoagulation TreatmentAnticoagulant TherapyAnticoagulant DrugsNOACsAnticoagulant Prophylaxis/TherapyAnticoagulation With NOACAnticoagulation With Direct Oral Anticoagulants
Trial Locations (1)
100053
RECRUITING
Xuanwu Hospital, Capital Medical University, Beijing